Drug Trial Radar · NCT06072131
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
504
Planned (sponsor's estimate)
Start
Oct 4, 2023
Primary completion
Jul 2030
Study completion Nov 2030
Sponsor
- Lead sponsor
- Acrotech Biopharma Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 10, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Part 1: This is a 5 Arm study primarily to determine the best dose out of the two dose levels of Belinostat and Pralatrexate combined with CHOP/COP in newly diagnosed PTCL patients based on Safety for part 2 study. Part 2 (Efficacy and Safety): This is a 3 Arm study. Patients with previously untreated PTCL will be randomized 1:1:1 into 1 of 3 treatment groups: 2 experimental treatment groups (Bel-CHOP or Fol-COP) or 1 active comparator treatment group (CHOP). Patients will be treated for up to 6 cycles. The primary objective is to compare the Progression Free Survival of patients with newly diagnosed PTCL treated for up to 6 cycles with Beleodaq (belinostat) in combination with CHOP (Bel-CHOP) or Folotyn (pralatrexate injection) in combination with COP (Fol-COP) to CHOP alone.
Conditions
- Peripheral T Cell Lymphoma
Interventions
Belinostat InjectionDrug
Belinostat 600 mg/m2 or 1000 mg/m2 along with CHOP is given in each cycle
Pralatrexate InjectionDrug
Pralatrexate 20 mg/m2 or 30 mg/m2 along with COP is given in each cycle
CHOPDrug
CHOP is the comparator arm
COPDrug
COP is given in combination with Pralatrexate
Primary outcomes
What the sponsor says the trial is designed to measure.
- PFSTime frame: 4.5 years
Locations
58 sites in 10 countries. Site status is shown where the registry gives one.
University of California, San Francisco Fresno
Clovis, California
University of California, Los Angeles Hem/ Onc Clinical Research Unit, Suite 600
Santa Monica, California
University of Colorado School of Medicine
Aurora, Colorado
Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System Memorial Cancer Institute
Pembroke Pines, Florida
Norton Cancer Institute
Louisville, Kentucky
Henry Ford Health System
Detroit, Michigan
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey
Ohio Health Research Institute
Columbus, Ohio
University of Texas, MD Anderson Cancer Center
Houston, Texas
Baylor Scott & White Medical Center - Temple
Temple, Texas
The Ottawa Hospital
Ottawa, Ontario, Canada
Princess Margaret Hospital
Toronto, Ontario, Canada
Universitatsmedizin Gottingen
Göttingen, Germany
Universitaetsklinikum Halle (Saale)
Halle, Germany
Semmelweis Egyetem
Budapest, Hungary
National Institute of Oncology
Budapest, Hungary
Belgyogyaszati Klinika es Kardiologiai Kozpont
Szeged, Hungary
University of Debrecen Clinical Center
Debrecen, Nagyerdei Krt. 98, Hungary
Andras Josa University Teaching Hospital
Nyíregyháza, Szent Istvan Utca, Hungary
Azienda Ospedaliera SS. Antonio e Biagio e C. Arrigo
Alessandria, Italy
Ospedale Policlinico San Martino, IRCCS
Genova, Italy
Azienda Ospedaliera Universitaria di Parma
Parma, Italy
Fondazione IRCCS Policlinico San Matteo
Pavia, Italy
Azienda USL di Ravenna
Ravenna, Italy
Azienda Ospedaliera Cardinale Giovanni Panico
Tricase, Apulia, Italy
University of Milano Bicocca
Milan, Bicocca, Italy
Servizio Sanitario Regionale Emilia-Romagna-Istituto Scientifico Romagnolo per lo Studio dei Tumori "Dino Amadori" Srl (IRST)
Meldola, Province Of Forlì-Cesena, Italy
Policlinico GB Rossi Borgo Roma
Borgo Roma, Verona, Italy
Pratia MCM Krakow
Krakow, Poland
Narodowy Instytut Onkologii im Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy
Warsaw, Poland
Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi
Lodz, Łódź Voivodeship, Poland
University Hospital in Wroclaw
Wroclaw, Wroclaw, Poland
Gachon University Gil Medical Center
Incheon, South Korea
Seoul National University Hospital
Seoul, South Korea
Inje University Busan Paik Hospital
Busan, Busanjin District, South Korea
Ajou University Hospital
Suwon, Gyenoggi-do, South Korea
The Catholic University of Korea - St. Vincents Hospital
Suwon, Gyeonggi-do, South Korea
Yeungnam University Medical Center
Daegu, Nam-gu, South Korea
Severance hospital, Yonsei University
Sinchon-dong, Seoul, South Korea
Asan Medical Center
Songpa-dong, Seoul, South Korea
Showing 40 of 58 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.